Differential effects of phototherapy, adalimumab and betamethasone-calcipotriol on effector and regulatory T cells in psoriasis.

Br J Dermatol 2018 Jul 26;179(1):127-135. Epub 2018 Apr 26.

Immunity, Infection and Inflammation Programme, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, U.K.

Background: Psoriasis is a chronic T-cell-mediated skin disease with marked social and economic burdens. Current treatments are unsatisfactory, with unpredictable remission times and incompletely understood modes of action. Recent advances in our understanding of the pathogenesis of psoriasis have identified the imbalance between CD4 T effector cells, particularly the T helper (Th)17 subset, and regulatory T cells (Tregs) as key to the development of psoriatic lesions, and therefore a novel therapeutic target.

Objectives: To quantify in patients the effects of three commonly used psoriasis treatment modalities on the Th1, Th2, Th17 and Treg subsets, and to test whether any change correlates with clinical response.

Methods: Flow cytometry was used to enumerate Th1, Th2, Th17 and Treg subsets in blood and skin of patients with psoriasis before and after receiving any of the following treatments: narrowband ultraviolet B (NB-UVB), adalimumab and topical betamethasone-calcipotriol combination (Dovobet ) RESULTS: All patients responded clinically to the treatments. NB-UVB significantly increased the numbers of circulating and skin Tregs, while, by contrast, adalimumab reduced Th17 cells in these compartments, and Dovobet had dual effects by both increasing Tregs and reducing Th17 cells.

Conclusions: The differential effects reported here for the above-mentioned treatment modalities could be exploited to optimize or design therapeutic strategies to overcome the inflammatory drivers more effectively and restore the Th17-Treg balance in psoriasis.

Abstract Video

Regulatory T cells as a therapeutic target in psoriasis, I.S. Kotb et al.


Source: British Journal of Dermatology

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.16336DOI Listing

Still can't find the full text of the article?

We can help you send a request to the authors directly.
July 2018
169 Reads

Publication Analysis

Top Keywords

th2 th17
8
th17 treg
8
regulatory cells
8
treg subsets
8
differential effects
8
th1 th2
8
treatment modalities
8
psoriasis
6
th17
5
lesions novel
4
increased numbers
4
novel therapeutic
4
therapeutic targetobjectives
4
patients effects
4
clinically treatments
4
quantify patients
4
targetobjectives quantify
4
numbers circulating
4
treatments nb-uvb
4
nb-uvb increased
4

Similar Publications